Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Regenerative Medicine is Transient Practice, Says Shinya Yamanaka

Filed Under: Innovation, Pharma Tagged With: , , , ,

Dr. Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), recently expressed his view that the…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…
Sekisui Chemical Moves Into Cell Culture Sector
Sekisui Chemical Moves Into Cell Culture Sector
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Nissan Chemical Eyes Global Expansion of High-Performance, Cost-Effective Cell Culture Supplement
Nissan Chemical Eyes Global Expansion of High-Performance,…